Management of paroxysmal nocturnal haemoglobinuria in clinical practice

Welcome to Management of paroxysmal nocturnal haemoglobinuria in clinical practice

An interactive discussion between experts

Join renowned Australian haematologists Prof Jeff Szer, Dr Danny Hsu, Dr Cecily Forsyth, and A/Prof Phillip Campbell in these enriching videos exploring the use of biomarkers in PNH management, and the identification and differentiation of intravascular haemolysys (IVH) and clinically significant extravascular haemolysis (cs-EVH).

Learning outcomes

By the end of this series,
participants will be able to:

  • Summarise the difference between IVH, cs-EVH and BTH and how to assess these in clinical practice.
  • Discuss the use of biomarkers in the differentiation of IVH and cs-EVH.
  • Discern between PNH patients with EVH vs other underlying causes of residual symptoms.

This website is intended for Australian Healthcare Professionals only.


Abbreviations: BTH, breakthrough haemolysis; cs-EVH, clinically significant extravascular haemolysis; IVH, intravascular haemolysis; PNH, paroxysmal nocturnal haemoglobinuria.